- Home
- DHF vs INGN Comparison
DHF vs INGN Comparison
Compare DHF & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DHF | INGN |
|---|---|---|
| Founded | 1998 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.7M | 186.8M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | DHF | INGN |
|---|---|---|
| Price | $2.52 | $7.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | ★ 451.1K | 156.2K |
| Earning Date | 01-01-0001 | 02-24-2026 |
| Dividend Yield | ★ 7.65% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $347,028,000.00 |
| Revenue This Year | N/A | $8.04 |
| Revenue Next Year | N/A | $8.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.68 |
| 52 Week Low | $2.06 | $5.70 |
| 52 Week High | $2.39 | $12.91 |
Technical Indicators
Market Signals| Indicator | DHF | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 54.18 | 59.28 |
| Support Level | $2.47 | $6.53 |
| Resistance Level | $2.54 | $7.46 |
| Average True Range (ATR) | 0.03 | 0.18 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 75.00 | 72.04 |
Price Performance
Historical ComparisonAbout DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. The fund invests predominantly in fixed-income securities of below-investment-grade credit quality.
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.